sabarubicin has been researched along with Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binaschi, M; Camarda, G; Goso, C; Maggi, CA | 1 |
| Arcamone, F; Bigioni, M; Casazza, A; Caserini, C; Dal Bo, L; De Cesare, M; Iafrate, E; Manzini, S; Perego, P; Polizzi, D; Pratesi, G; Salvatore, C; Supino, R; Zunino, F | 1 |
2 other study(ies) available for sabarubicin and Carcinoma
| Article | Year |
|---|---|
Nuclear factor-kappaB, induced in human carcinoma cell line A2780 by the new anthracycline men 10755, is devoid of transcriptional activity.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma; Disaccharides; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; NF-kappa B; Transcriptional Activation; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma; Disaccharides; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Proto-Oncogene Proteins c-bcl-2; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |